Trailing-twelve-month (TTM) revenue is $689.25 Million with a year-over-year growth of (20.87%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $164,645,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $219,160,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $148,917,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-01 |
| Q2 FY2026Period ended 2026-06-30 | $156,525,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $689,247,000 |
Current P/S: $1,554,583,322 market capitalization ÷ $689,247,000 TTM revenue = 2.26x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:55:15.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $156.53M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:58:21.783Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Non-US | $142M | $154M | $118M | $125M | N/A |
| Other International Countries | N/A | N/A | N/A | N/A | $87M |
$689.25M
$689.25 Million
(20.87%)
vs. $871.03M a year ago (TTM)
+7.67%
5 Year compound annual growth rate
1 Year
(20.87%)
3 Year
+3.29%
5 Year
+7.67%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $750.90M | ($127.14M) | (14.48%) |
| 2024 | $878.04M | +$229.39M | +35.36% |
| 2023 | $648.65M | +$17.14M | +2.71% |
| 2022 | $631.51M | ($170.16M) | (21.23%) |
| 2021 | $801.66M | +$282.68M | +54.47% |
| 2020 |
TTM Growth
(20.87%)
3-Year CAGR
+3.29%
5-Year CAGR
+7.67%
| UNITED STATES |
|---|
| $660M |
| $478M |
| $530M |
| $753M |
| $563M |
| $518.99M |
| ($14.31M) |
| (2.68%) |
| 2019 | $533.30M | ($146.27M) | (21.52%) |
